Clark Financial Services Group Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Clark Financial Services Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$5.12 - $8.19 $106,915 - $171,023	-20,882 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.68 - $9.1 $1,623 - $2,211	243 Added 1.18%	20,882 $140,000
Q2 2021 Aug 09, 2021	BUY	$7.82 - $9.23 $13,325 - $15,727	1,704 Added 9.0%	20,639 $176,000
Q1 2021 May 17, 2021	BUY	$8.44 - $12.66 $159,811 - $239,717	18,935 New	18,935 $167,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

Stay updated on Clark Financial Services Group Inc with notifications on news.